Precision Biosciences (DTIL) Cash from Investing Activities (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64.92% |
| Dec 31, 2025 | -2,011.76% |
| Sep 30, 2025 | 241.67% |
| Jun 30, 2025 | 96.18% |
| Mar 31, 2025 | -223.71% |
| Dec 31, 2024 | -51.56% |
| Sep 30, 2024 | -128.57% |
| Jun 30, 2024 | -7.69% |
| Mar 31, 2024 | -161.90% |
| Dec 31, 2023 | -99.44% |
| Sep 30, 2023 | 816.29% |
| Jun 30, 2023 | -46.46% |
| Mar 31, 2023 | -14.08% |
| Dec 31, 2022 | 42.02% |
| Sep 30, 2022 | -39.92% |
| Jun 30, 2022 | 4.77% |
| Mar 31, 2022 | 45.65% |
| Dec 31, 2021 | -1.48% |
| Sep 30, 2021 | 12.25% |
| Jun 30, 2021 | -50.22% |
| Mar 31, 2021 | -2.65% |
| Dec 31, 2020 | -4.68% |
| Sep 30, 2020 | 41.34% |
| Jun 30, 2020 | -61.83% |
| Mar 31, 2020 | 80.05% |
| Dec 31, 2019 | 6.57% |
| Sep 30, 2019 | 27.27% |
| Jun 30, 2019 | -60.11% |
| Mar 31, 2019 | 48.52% |
| Dec 31, 2018 | -144.03% |
| Sep 30, 2018 | -258.60% |
| Jun 30, 2018 | -82.23% |